Send us a text

This episode features Teresa Whalen, CEO, CytoAgents. Learn about Teresa's motivation to keeping patients at the forefront of her work, her experience as a leader in the life sciences industry, advice on how to fundraise in a difficult environment and how CytoAgents was able to secure NIH funding to advance the research on cytokine release syndrome (CRS).